North America Exosome Diagnostic and Therapeutic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Application (Diagnostic and Therapeutic); Product (Instruments, Reagents, and Software); End User (Cancer Institute, Hospitals, Diagnostic Centers, and Other End Users), and Country
The exosome diagnostic and therapeutic market in North America is expected to grow from US$ 17,578.32 thousand in 2019 to US$ 154,116.95 thousand by 2027. This represents a CAGR of 32.5% from 2020 to 2027.
The growth of the market in the region is expected to grow owing to increased demand for the use of exosomes as biomarkers in the diagnosis of cancer, increasing prevalence of cancer, aging population and lifestyle changes. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the North American exosome diagnostic and therapeutic market during the forecast period.
The US has observed fast growth in the exosome diagnostic and therapeutic market within the past few years and is expected to lead the market in North America during the forecast period. Currently, exosomes are rapidly gaining momentum in accessing therapeutic effects of stem cells. Additionally, they hold great promise for use as biomarkers in non-invasive tests, vehicles for drug delivery, and active agents in cosmeceutical products. Investment has also increased in manufacturing technologies to support the production of clinical-grade stem cell exosomes. For instance, in 2017, RoosterBio and Exopharm collaborated on a Stem Cell Exomere Program. The objective of the project is to develop therapeutic extracellular exosomes derived from adult stem cells into clinical practice. Licensing activity has also increased in the industry offering lucrative opportunities for the growth of the market in the US. Further, in 2014, Capricor Therapeutics added seven new patent applications with Cedars-Sinai Medical Center for technologies related to cardiosphere-derived cells (CDCs) and CDC-derived extracellular vesicles, including exosomes.
US Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (US$ Thousand)
Get more information on this report :
NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC – MARKET SEGMENTATION
North America Exosome Diagnostic and Therapeutic Market - By Application
- Diagnostic
- Therapeutic
North America Exosome Diagnostic and Therapeutic Market - By Product
- Instruments
- Reagents
- Software
North America Exosome Diagnostic and Therapeutic Market - By End User
- Cancer Institutes
- Hospitals
- Diagnostic Centers
- Others
North America Exosome Diagnostic and Therapeutic Market - By Country
- US
- Canada
- Mexico
Company Profiles
- AETHLON MEDICAL, INC
- BIOREGENERATIVE SCIENCES
- Cell Guidance Systems
- Evomic Science LLC
- EXOSOME DIAGNOSTICS
- ITH, Immune Therapy Holdings AB
- Miltenyi Biotec
- Norgen Biotek Corp
- RENEURON GROUP PLC
- Therapeutic Solutions International, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Exosome diagnostic and therapeutic Market – By Application
1.3.2 North America Exosome diagnostic and therapeutic Market – By Product
1.3.3 North America Exosome diagnostic and therapeutic Market – By End User
1.3.4 North America Exosome Diagnostic and Therapeutic Market – By Country
2. Exosome Diagnostic and Therapeutic Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Exosome Diagnostic and Therapeutic Market – Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America – PEST Analysis
5. North America Exosome Diagnostic and Therapeutic Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
5.1.2 Rise in Research and Development Activities
5.2 Key Market Restraints
5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
5.3 Key Market Opportunities
5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
5.4 Future Trends
5.4.1 Automation of Exosome Isolation Process
5.5 Impact analysis
6. Exosome Diagnostic and Therapeutic Market– Regional Analysis
6.1 North America Exosome Diagnostic and Therapeutic Market Revenue Forecast and Analysis
7. Exosome Diagnostic and Therapeutic Market Analysis – By Application
7.1 Overview
7.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
7.3 Diagnostic
7.3.1 Overview
7.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
7.4 Therapeutic
7.4.1 Overview
7.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
8. Exosome Diagnostic and Therapeutic Market Analysis – By Product
8.1 Overview
8.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
8.3 Instruments
8.3.1 Overview
8.3.2 Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.4 Reagents
8.4.1 Overview
8.4.2 Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
8.5 Software
8.5.1 Overview
8.5.2 Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
9. Exosome Diagnostic and Therapeutic Market Analysis – By End User
9.1 Overview
9.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
9.3 Cancer Institutes
9.3.1 Overview
9.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
9.5 Diagnostic Centres
9.5.1 Overview
9.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
9.6 Other End User
9.6.1 Overview
9.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
10. Exosome Diagnostic and Therapeutic Market – Geographic Analysis
10.1 North America: Exosome Diagnostic and Therapeutic Market
10.1.1 Overview
10.1.2 North America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.3 North America: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)
10.1.4 North America: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
10.1.5 North America: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
10.1.6 North America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
10.1.7 US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
10.1.7.1 US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
10.1.7.2 US: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
10.1.7.3 US: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
10.1.7.4 US: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
10.1.8 Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
10.1.8.1 Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
10.1.8.2 Canada: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
10.1.8.3 Canada: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
10.1.8.4 Canada: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
10.1.9 Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
10.1.9.1 Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
10.1.9.2 Mexico: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)
10.1.9.3 Mexico: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)
10.1.9.4 Mexico: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)
11. Impact Of Covid-19 Pandemic On North America Exosome Diagnostic And Therapeutic Market
11.1 North America: Impact assessment of COVID-19 Pandemic
12. Exosome Diagnostic and Treatment Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in The Exosome Diagnostic And Treatment Market, 2017-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Cell Guidance Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BIOREGENERATIVE SCIENCES
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Evomic Science LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Norgen Biotek Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Miltenyi Biotec
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Therapeutic Solutions International, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 SWOT Analysis
13.6.5 Key Developments
13.7 AETHLON MEDICAL, INC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 RENEURON GROUP PLC
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ITH, Immune Therapy Holdings AB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 EXOSOME DIAGNOSTICS
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousands)
Table 2. North America Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 3. North America Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 4. US Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 5. US Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 6. US Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 7. Canada Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 8. Canada Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 9. Canada Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 10. Mexico Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)
Table 11. Mexico Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)
Table 12. Mexico Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)
Table 14. Recent Inorganic Growth Strategies in The Exosome Diagnostic and Treatment Market
Table 15. Recent Organic Growth Strategies in The Exosome Diagnostic and Treatment Market
Table 16. Glossary of Terms, Exosome diagnostic and treatment market
LIST OF FIGURES
Figure 1. Exosome Diagnostic and Therapeutic Market Segmentation
Figure 2. Exosome Diagnostic and Therapeutic Segmentation, By Country
Figure 3. North America Exosome Diagnostic and Therapeutic Market Overview
Figure 4. Diagnostics Held Largest Share of Application Segment in Exosome diagnostic and Therapeutic Market
Figure 5. US Region Is Expected to Show Remarkable Growth during the Forecast Period
Figure 6. North America Exosome Diagnostic and Therapeutic Market- Leading Country Markets (US$ Thousand)
Figure 7. North America Exosome Diagnostic and Therapeutic Market, Industry Landscape
Figure 8. North America PEST Analysis
Figure 9. Exosome diagnostic and therapeutic market impact analysis of driver and restraints
Figure 10. North America Exosome Diagnostic and Therapeutic Market– Revenue Forecast and Analysis – 2019- 2027
Figure 11. Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
Figure 12. Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 13. Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 14. Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)
Figure 15. Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 16. Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 17. Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 18. Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)
Figure 19. Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 20. Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 21. Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 22. Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
Figure 23. North America: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)
Figure 24. US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 25. Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 26. Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 27. Impact Of Covid-19 Pandemic In North American Country Markets
Figure 28. Growth Strategies in the Exosome Diagnostic And Treatment Market, 2017-2020
The List of Companies - North America Exosome Diagnostic and Therapeutic Market
- AETHLON MEDICAL, INC
- BIOREGENERATIVE SCIENCES
- Cell Guidance Systems
- Evomic Science LLC
- EXOSOME DIAGNOSTICS
- ITH, Immune Therapy Holdings AB
- Miltenyi Biotec
- Norgen Biotek Corp
- RENEURON GROUP PLC
- Therapeutic Solutions International, Inc.
- Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the North American exosome diagnostic and therapeutic market
- Highlights key business priorities to assist companies in order to realign their business strategies
- Highlights key findings and recommendations of crucial progressive industry trends in the North American exosome diagnostic and therapeutic market, thereby allowing players across the value chain to develop effective long-term strategies
- Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinizes in-depth North American market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution